500,000 women are diagnosed with cervical cancer annually with the overwhelming majority of deaths taking place in the most impoverished parts of the world due to screening limitations. 

Mercy invented Calla, a convenient, low cost self screening imaging device for cervical cancer. Calla uses algorithms from imaging data, analyzing risk assessment and integrates with a mobile app to store patient data on the cloud.